Senior Director of Regulatory Policy and Intelligence
Bristol-Myers Squibb
Nadège has a strong background in regulatory science and policy comprising regulatory development and life-cycle management with more than 25 years of experience. She is actively engaging in various expert groups and steering committees in European trade associations. In her current position, she acts as Regulatory Intelligence and Policy Lead within BMS, Global Regulatory Policy. Her topics of focus are the EU Pharmaceutical reform, HTA synergies, Expedited Pathways, Digitalization transformation, RWE/RWD, Orphan, … She is graduated of PhD in Bioethics and public health from Medicine University of Necker – Paris Descartes and Post-Graduated research in Pharmacology/Pharmaco-dynamy at University of Pharmacy in Marseille.
Disclosure information not submitted.
EMA's PRIME Scheme in Review: Findings, Lessons Learnt and Future Directions
Friday, May 12, 2023
10:45 – 11:45 CEST